Literature DB >> 9389643

Human telomerase contains evolutionarily conserved catalytic and structural subunits.

L Harrington1, W Zhou, T McPhail, R Oulton, D S Yeung, V Mar, M B Bass, M O Robinson.   

Abstract

We have cloned and characterized a human gene encoding TP2 (telomerase-associated protein 2), a protein with similarity to reverse transcriptases and the catalytic telomerase subunits from Saccharomyces cerevisiae and Euplotes aediculatus. Indirect immunofluorescence revealed that TP2 was localized to the nucleus. Using antibodies to endogenous and epitope-tagged TP2, we found that TP2 was associated specifically with human telomerase activity and the recently identified telomerase-associated protein TP1. Mutation of conserved residues within the reverse transcriptase domain of TP2 severely reduced associated telomerase activity. These results suggest that telomerase is an evolutionarily conserved multisubunit complex composed of both structural and catalytic subunits.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9389643      PMCID: PMC316744          DOI: 10.1101/gad.11.23.3109

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  37 in total

1.  A conserved pseudoknot in telomerase RNA.

Authors:  E ten Dam; A van Belkum; K Pleij
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

2.  Functional characterization and developmental regulation of mouse telomerase RNA.

Authors:  M A Blasco; W Funk; B Villeponteau; C W Greider
Journal:  Science       Date:  1995-09-01       Impact factor: 47.728

Review 3.  Telomerase and telomere-binding proteins: controlling the endgame.

Authors:  D Shore
Journal:  Trends Biochem Sci       Date:  1997-07       Impact factor: 13.807

4.  Runaway telomere elongation caused by telomerase RNA gene mutations.

Authors:  M J McEachern; E H Blackburn
Journal:  Nature       Date:  1995-08-03       Impact factor: 49.962

5.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

6.  The anchor site of telomerase from Euplotes aediculatus revealed by photo-cross-linking to single- and double-stranded DNA primers.

Authors:  P W Hammond; T N Lively; T R Cech
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

7.  Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes.

Authors:  T S Lendvay; D K Morris; J Sah; B Balasubramanian; V Lundblad
Journal:  Genetics       Date:  1996-12       Impact factor: 4.562

8.  Reverse transcriptase motifs in the catalytic subunit of telomerase.

Authors:  J Lingner; T R Hughes; A Shevchenko; M Mann; V Lundblad; T R Cech
Journal:  Science       Date:  1997-04-25       Impact factor: 47.728

9.  Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.

Authors:  H Vaziri; W Dragowska; R C Allsopp; T E Thomas; C B Harley; P M Lansdorp
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

10.  Architecture of telomerase RNA.

Authors:  A Bhattacharyya; E H Blackburn
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

View more
  126 in total

1.  Two inactive fragments of the integral RNA cooperate to assemble active telomerase with the human protein catalytic subunit (hTERT) in vitro.

Authors:  V M Tesmer; L P Ford; S E Holt; B C Frank; X Yi; D L Aisner; M Ouellette; J W Shay; W E Wright
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Identification of functionally important domains in the N-terminal region of telomerase reverse transcriptase.

Authors:  J Xia; Y Peng; I S Mian; N F Lue
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

3.  Interference footprinting analysis of telomerase elongation complexes.

Authors:  S Benjamin; N Baran; H Manor
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  Three telomerases with completely non-telomeric template replacements are catalytically active.

Authors:  T L Ware; H Wang; E H Blackburn
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

5.  Telomere maintenance in telomerase-deficient mouse embryonic stem cells: characterization of an amplified telomeric DNA.

Authors:  H Niida; Y Shinkai; M P Hande; T Matsumoto; S Takehara; M Tachibana; M Oshimura; P M Lansdorp; Y Furuichi
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

6.  Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence.

Authors:  R V Lord; D Salonga; K D Danenberg; J H Peters; T R DeMeester; J M Park; J Johansson; K A Skinner; P Chandrasoma; S R DeMeester; C G Bremner; P I Tsai; P V Danenberg
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

7.  Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells.

Authors:  M J O'Hare; J Bond; C Clarke; Y Takeuchi; A J Atherton; C Berry; J Moody; A R Silver; D C Davies; A E Alsop; A M Neville; P S Jat
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

8.  The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity.

Authors:  L M Colgin; C Wilkinson; A Englezou; A Kilian; M O Robinson; R R Reddel
Journal:  Neoplasia       Date:  2000 Sep-Oct       Impact factor: 5.715

9.  Polymerization defects within human telomerase are distinct from telomerase RNA and TEP1 binding.

Authors:  T L Beattie; W Zhou; M O Robinson; L Harrington
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

Review 10.  Complex regulation of telomerase activity: implications for cancer therapy.

Authors:  K S Elenitoba-Johnson
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.